The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
Authors
Keywords
-
Journal
Targeted Oncology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-17
DOI
10.1007/s11523-018-0565-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting autophagy blocks melanoma growth by bringing natural killer cells to the tumor battlefield
- (2018) Muhammad Zaeem Noman et al. Autophagy
- miR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma
- (2018) Meiying Luo et al. CELLULAR SIGNALLING
- Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells
- (2018) Hiroyuki Monma et al. PLoS One
- The environment, epigenome, and asthma
- (2017) Ivana V. Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
- (2017) Liang Cheng et al. MODERN PATHOLOGY
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1
- (2017) S-H Chen et al. ONCOGENE
- Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury
- (2017) Amanda Brosius Lutz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
- (2017) Jae-Hyeon Kim et al. Cancer Research and Treatment
- Implication of Unfolded Protein Response and Autophagy in the Treatment of BRAF Inhibitor Resistant Melanoma
- (2016) Xiao-Xiao Meng et al. Anti-Cancer Agents in Medicinal Chemistry
- Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice
- (2016) Jihye Han et al. Autophagy
- The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34
- (2016) J. M. Backer BIOCHEMICAL JOURNAL
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Encorafenib (LGX818), a potent BRAF inhibitor, induces senescence accompanied by autophagy in BRAFV600E melanoma cells
- (2016) Zhen Li et al. CANCER LETTERS
- Structure and function of the ULK1 complex in autophagy
- (2016) Mary G Lin et al. CURRENT OPINION IN CELL BIOLOGY
- The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
- (2016) Christopher P Webster et al. EMBO JOURNAL
- BRAF V600E-dependent role of autophagy in uveal melanoma
- (2016) Yinu Zhao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Overall Survival and Durable Responses in Patients WithBRAFV600–Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
- (2016) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation
- (2016) I. C. Waizenegger et al. MOLECULAR CANCER THERAPEUTICS
- The state of melanoma: challenges and opportunities
- (2016) Glenn Merlino et al. Pigment Cell & Melanoma Research
- Endoplasmic reticulum stress-induced autophagy determines the susceptibility of melanoma cells to dabrafenib
- (2016) Bo Cheng et al. Drug Design Development and Therapy
- BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells
- (2016) Maria Goulielmaki et al. Oncotarget
- Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
- (2016) Mack Y. Su et al. PLOS MEDICINE
- Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
- (2015) Brian A. Boone et al. ANNALS OF SURGICAL ONCOLOGY
- A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90
- (2015) Christopher NJ Young et al. Autophagy
- Autophagy sustains the survival of human pancreatic cancer PANC-1 cells under extreme nutrient deprivation conditions
- (2015) Sang Eun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells
- (2015) S. Martin et al. BIOCHEMICAL PHARMACOLOGY
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth
- (2015) T. Wang et al. CLINICAL CANCER RESEARCH
- TBC1D14 regulates autophagy via the TRAPP complex and ATG9 traffic
- (2015) C. A. Lamb et al. EMBO JOURNAL
- Autophagy in malignant transformation and cancer progression
- (2015) L. Galluzzi et al. EMBO JOURNAL
- Compromised autophagy and neurodegenerative diseases
- (2015) Fiona M. Menzies et al. NATURE REVIEWS NEUROSCIENCE
- TSH overcomes Braf V600E -induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer
- (2015) M Zou et al. ONCOGENE
- Atg13 HORMA domain recruits Atg9 vesicles during autophagosome formation
- (2015) Sho W. Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
- (2015) Francesco Spagnolo et al. OncoTargets and Therapy
- Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma
- (2015) X. Xie et al. Cancer Discovery
- Melanoma
- (2015) Dirk Schadendorf et al. Nature Reviews Disease Primers
- Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
- (2015) Kenar D. Jhaveri et al. JAMA Oncology
- Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition
- (2014) S. Turajlic et al. ANNALS OF ONCOLOGY
- Autophagy suppresses melanoma tumorigenesis by inducing senescence
- (2014) He Liu et al. Autophagy
- Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib
- (2014) Megan L Goodall et al. Autophagy
- Transcriptional regulation ofATG9by the Pho23-Rpd3 complex modulates the frequency of autophagosome formation
- (2014) Meiyan Jin et al. Autophagy
- Combined MTOR and autophagy inhibition
- (2014) Reshma Rangwala et al. Autophagy
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- Molecular pathology of malignant melanoma: changing the clinical practice paradigm toward a personalized approach
- (2014) Joshua R. Bradish et al. HUMAN PATHOLOGY
- Assessment of ER Stress and Autophagy Induced by Ionizing Radiation in Both Radiotherapy Patients and Ex Vivo Irradiated Samples
- (2014) Emel Saglar et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
- (2014) Xiao-Hong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Autophagy in Antimicrobial Immunity
- (2014) Ligia C. Gomes et al. MOLECULAR CELL
- Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
- (2014) B. M. Wolpin et al. ONCOLOGIST
- P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells
- (2014) Ying Qiu et al. PLoS One
- Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
- (2014) Yingxi Xu et al. TRENDS IN BIOCHEMICAL SCIENCES
- BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma
- (2014) YONG WANG et al. Oncology Letters
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNF
- (2014) M. P. Smith et al. Cancer Discovery
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Functional features of cancer stem cells in melanoma cell lines
- (2013) Rüdiger M Zimmerer et al. Cancer Cell International
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- Early signalling events of autophagy
- (2013) Laura E. Gallagher et al. Essays in Biochemistry
- Towards personalized therapy for patients with malignant melanoma: molecular insights into the biology of BRAF mutations
- (2013) Joshua R Bradish et al. Future Oncology
- Chloroquine: Modes of action of an undervalued drug
- (2013) Rodolfo Thomé et al. IMMUNOLOGY LETTERS
- MERTK receptor tyrosine kinase is a therapeutic target in melanoma
- (2013) Jennifer Schlegel et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- The autophagosome: origins unknown, biogenesis complex
- (2013) Christopher A. Lamb et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression
- (2013) Wafa B’chir et al. NUCLEIC ACIDS RESEARCH
- Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression
- (2013) Mabel Ryder et al. PLoS One
- High dose of extracellular ATP switched autophagy to apoptosis in anchorage-dependent and anchorage-independent hepatoma cells
- (2013) Qing Wei et al. Purinergic Signalling
- A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition
- (2013) H. Shi et al. Cancer Discovery
- A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
- (2013) Steven R. Whittaker et al. Cancer Discovery
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus
- (2012) Marina Pierdominici et al. FASEB JOURNAL
- Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
- (2012) L. C. W. Vredeveld et al. GENES & DEVELOPMENT
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- Atg9 vesicles are an important membrane source during early steps of autophagosome formation
- (2012) Hayashi Yamamoto et al. JOURNAL OF CELL BIOLOGY
- BRAF/NRASMutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
- (2012) Maria Colombino et al. JOURNAL OF CLINICAL ONCOLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
- (2012) Maria R. Girotti et al. Cancer Discovery
- Autophagy as a therapeutic target in cancer
- (2011) Ning Chen et al. CANCER BIOLOGY & THERAPY
- Autophagy: Renovation of Cells and Tissues
- (2011) Noboru Mizushima et al. CELL
- AMPK Activates Autophagy by Phosphorylating ULK1
- (2011) Kai Mao et al. CIRCULATION RESEARCH
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Unleashing the Ambra1-Beclin 1 complex from dynein chains: Ulk1 sets Ambra1 free to induce autophagy
- (2010) Gian Maria Fimia et al. Autophagy
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
- (2010) Jessie Villanueva et al. CANCER CELL
- Extracellular ATP May Contribute to Tissue Repair by Rapidly Stimulating Purinergic Receptor X7-Dependent Vascular Endothelial Growth Factor Release from Primary Human Monocytes
- (2010) L. M. Hill et al. JOURNAL OF IMMUNOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Extracellular ATP activates MAP kinase cascades through a P2Y purinergic receptor in the human intestinal Caco-2 cell line
- (2009) Natalia Buzzi et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
- (2009) V. Raja Solomon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy
- (2009) Ian G. Ganley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy Machinery
- (2009) Chang Hwa Jung et al. MOLECULAR BIOLOGY OF THE CELL
- Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complex
- (2009) Yun Zhong et al. NATURE CELL BIOLOGY
- Extracellular ATP activates the PLC/PKC/ERK signaling pathway through the P2Y2 purinergic receptor leading to the induction of early growth response 1 expression and the inhibition of viability in human endometrial stromal cells
- (2008) Shu-Ju Chang et al. CELLULAR SIGNALLING
- Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum
- (2008) Elizabeth L. Axe et al. JOURNAL OF CELL BIOLOGY
- Kinase-Inactivated ULK Proteins Inhibit Autophagy via Their Conserved C-Terminal Domains Using an Atg13-Independent Mechanism
- (2008) E. Y. W. Chan et al. MOLECULAR AND CELLULAR BIOLOGY
- The Atg16L Complex Specifies the Site of LC3 Lipidation for Membrane Biogenesis in Autophagy
- (2008) Naonobu Fujita et al. MOLECULAR BIOLOGY OF THE CELL
- Beclin 1 Forms Two Distinct Phosphatidylinositol 3-Kinase Complexes with Mammalian Atg14 and UVRAG
- (2008) Eisuke Itakura et al. MOLECULAR BIOLOGY OF THE CELL
- Many roads lead to oncogene-induced senescence
- (2008) S Courtois-Cox et al. ONCOGENE
- Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase
- (2008) Q. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now